- Report
- May 2024
- 133 Pages
Global
From €5835EUR$6,499USD£4,969GBP
- Report
- May 2024
- 134 Pages
Global
From €5835EUR$6,499USD£4,969GBP
- Report
- November 2023
- 172 Pages
Global
From €3231EUR$3,599USD£2,752GBP
- Report
- April 2023
- 147 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- January 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- January 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- October 2023
- 145 Pages
Global
From €2828EUR$3,150USD£2,408GBP
- Report
- May 2024
- 160 Pages
Global
From €4461EUR$4,969USD£3,799GBP
- Report
- February 2024
- 180 Pages
Global
From €4461EUR$4,969USD£3,799GBP
- Report
- May 2023
- 160 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- March 2023
- 147 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- July 2023
- 129 Pages
Global
From €6734EUR$7,500USD£5,735GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Report
- April 2023
- 165 Pages
Global
From €6734EUR$7,500USD£5,735GBP
- Report
- September 2022
- 30 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Report
- August 2022
- 30 Pages
Global
From €2918EUR$3,250USD£2,485GBP
- Report
- January 2022
- 200 Pages
Global
From €6734EUR$7,500USD£5,735GBP
- Report
- January 2022
- 60 Pages
Global
From €3547EUR$3,950USD£3,020GBP
- Report
- November 2023
- 161 Pages
Global
From €2245EUR$2,500USD£1,912GBP
- Report
- June 2024
- 200 Pages
Global
From €7138EUR$7,950USD£6,079GBP

The Antidepressant market is a subset of the Mental Disorders Drugs market, which includes medications used to treat mental health conditions such as depression, anxiety, bipolar disorder, and schizophrenia. Antidepressants are the most commonly prescribed medications for treating depression, and are typically divided into two categories: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications work by increasing the levels of serotonin and norepinephrine in the brain, which can help to improve mood and reduce symptoms of depression.
Some of the major companies in the Antidepressant market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. These companies produce a variety of antidepressants, including SSRIs and SNRIs, as well as other medications used to treat mental health conditions. Show Less Read more